1133229-30-7

Levetiracetam-d₆ is intended for use as an internal standard for the quantification of levetiracetam by GC- or LC-MS. Levetiracetam is an antiepileptic agent that binds to the synaptic vesicle protein SV2A (IC₅₀ = 1.99 μM). In vivo, levetiracetam suppresses seizures in fully kindled rats.

Levetiracetam-d6 is a labelled (S)-enantiomer of the ethyl analog of Piracetam (P500800), an anticonvulsant.

LevetiracetaM-d6 is the labelled (S)-enantiomer of the ethyl analog of Piracetam,it is uUsed as an anticonvulsant.

Store at -20°C

[1] BERKLEY A LYNCH. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam.[J]. Proceedings of the National Academy of Sciences of the United States of America, 2004, 101 26: 9861-9866. DOI: 10.1073/pnas.0308208101
[2] WOLFGANG L?SCHER C B. Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research.[J]. Pharmacological Reviews, 2010, 62 4: 668-700. DOI: 10.1124/pr.110.003046